Display options
Cite
Voorwerk L, Slagter M, Horlings HM, et al. Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. Nat Med. 2019;25(7):1175doi: 10.1038/s41591-019-0520-5.
Voorwerk, L., Slagter, M., Horlings, H. M., Sikorska, K., van de Vijver, K. K., de Maaker, M., Nederlof, I., Kluin, R. J. C., Warren, S., Ong, S., Wiersma, T. G., Russell, N. S., Lalezari, F., Schouten, P. C., Bakker, N. A. M., Ketelaars, S. L. C., Peters, D., Lange, C. A. H., van Werkhoven, E., van Tinteren, H., Mandjes, I. A. M., Kemper, I., Onderwater, S., Chalabi, M., Wilgenhof, S., Haanen, J. B. A. G., Salgado, R., de Visser, K. E., Sonke, G. S., Wessels, L. F. A., Linn, S. C., Schumacher, T. N., Blank, C. U., & Kok, M. (2019). Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. Nature medicine, 25(7), 1175. https://doi.org/10.1038/s41591-019-0520-5
Voorwerk, Leonie, et al. "Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial." Nature medicine vol. 25,7 (2019): 1175. doi: https://doi.org/10.1038/s41591-019-0520-5
Voorwerk L, Slagter M, Horlings HM, Sikorska K, van de Vijver KK, de Maaker M, Nederlof I, Kluin RJC, Warren S, Ong S, Wiersma TG, Russell NS, Lalezari F, Schouten PC, Bakker NAM, Ketelaars SLC, Peters D, Lange CAH, van Werkhoven E, van Tinteren H, Mandjes IAM, Kemper I, Onderwater S, Chalabi M, Wilgenhof S, Haanen JBAG, Salgado R, de Visser KE, Sonke GS, Wessels LFA, Linn SC, Schumacher TN, Blank CU, Kok M. Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial. Nat Med. 2019 Jul;25(7):1175. doi: 10.1038/s41591-019-0520-5. PMID: 31209337.
Copy Download .nbib Format: NLM
Share it on

Nat Med. 2019 Jul;25(7):1175. doi: 10.1038/s41591-019-0520-5.

Publisher Correction: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial.

Nature medicine

Leonie Voorwerk, Maarten Slagter, Hugo M Horlings, Karolina Sikorska, Koen K van de Vijver, Michiel de Maaker, Iris Nederlof, Roelof J C Kluin, Sarah Warren, SuFey Ong, Terry G Wiersma, Nicola S Russell, Ferry Lalezari, Philip C Schouten, Noor A M Bakker, Steven L C Ketelaars, Dennis Peters, Charlotte A H Lange, Erik van Werkhoven, Harm van Tinteren, Ingrid A M Mandjes, Inge Kemper, Suzanne Onderwater, Myriam Chalabi, Sofie Wilgenhof, John B A G Haanen, Roberto Salgado, Karin E de Visser, Gabe S Sonke, Lodewyk F A Wessels, Sabine C Linn, Ton N Schumacher, Christian U Blank, Marleen Kok

Affiliations

  1. Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  2. Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  3. Oncode Institute, Utrecht, the Netherlands.
  4. Department of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  5. Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  6. Department of Pathology, Ghent University Hospital, Ghent, Belgium.
  7. Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  8. Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  9. NanoString Technologies, Inc, Seattle, WA, USA.
  10. Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  11. Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  12. Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  13. Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  14. Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  15. Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  16. Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium.
  17. Division of Research, Peter Mac Callum Cancer Center, Melbourne, Victoria, Australia.
  18. Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. [email protected].
  19. Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. [email protected].

PMID: 31209337 DOI: 10.1038/s41591-019-0520-5

Abstract

In the version of this article originally published, there was an error in Fig. 3j. A label on the heatmap read "TGF-α signaling via NF-κB". It should have read "TNF-α signaling via NF-κB". The error has been corrected in the HTML and PDF versions of this article.

Publication Types